Targeting Akt Signaling Pathway in Cancer: Molecular Mechanisms and Advances in Therapeutic Interventions

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The Akt/protein kinase B (PKB) pathway is a critical signaling axis downstream of phosphoinositide 3-kinase (PI3K).
• Akt regulates fundamental cellular processes including growth, proliferation, apoptosis, survival, and migration.
• In cancer, the equilibrium of Akt pathway components is disrupted, promoting tumor development.

Purpose of the Study:

• To review the role of the Akt signaling pathway in cancer.
• To discuss current Akt-targeted therapeutic agents and their limitations.
• To explore future directions for Akt-targeted cancer therapies.

Main Methods:

• Literature review of Akt signaling in cancer.
• Analysis of current Akt-targeted agents and their clinical efficacy.
• Discussion of molecular mechanisms and therapeutic strategies.

Main Results:

• The Akt pathway is frequently dysregulated in various cancers due to mutations.
• Current Akt inhibitors show promise but face challenges like resistance and toxicity.
• Targeting downstream effectors of Akt may offer alternative therapeutic avenues.

Conclusions:

• Understanding Akt pathway dysregulation is vital for effective cancer treatment.
• Development of novel Akt-targeting agents and combination therapies is ongoing.
• Future research should focus on overcoming therapeutic limitations and exploring new targets within the Akt pathway.